...
首页> 外文期刊>Cancer Imaging >Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution
【24h】

Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution

机译:胞内比较68GA-PSMA-11和18F-DCFP氨基核生物分布

获取原文
           

摘要

Detailed data comparing the biodistribution of PSMA radioligands is still scarce, raising concerns regarding the comparability of different compounds. We investigated differences in normal-organ biodistribution and uptake variability between the two most commonly PSMA tracers in clinical use, 68Ga-PSMA-11 and 18F-DCFPyL. This retrospective analysis included 34 patients with low tumor burden referred for PET/CT imaging with 68Ga-PSMA-11 and subsequently 18F-DCFPyL. Images were acquired with 4 cross-calibrated PET/CT systems. Volumes of interest were placed on major salivary and lacrimal glands, liver, spleen, duodenum, kidneys, bladder, blood-pool and muscle. Normal-organ biodistribution of both tracers was then quantified as SUVpeak and compared using paired tests, linear regression and Bland-Altman analysis. Between-patient variability was also assessed. Clinical and protocol variables were investigated for possible interference. For both tracers the highest uptake was found in the kidneys and bladder and low background activity was noted across all scans. In the quantitative analysis there was significantly higher uptake of 68Ga-PSMA-11 in the kidneys, spleen and major salivary glands (p???0.001), while the liver exhibited slightly higher 18F-DCFPyL uptake (p?=?0.001, mean bias 0.79?±?1.30). The lowest solid-organ uptake variability was found in the liver (COV 21.9% for 68Ga-PSMA-11, 22.5% for 18F-DCFPyL). There was a weak correlation between 18F-DCFPyL uptake time and liver SUVpeak (r?=?0.488, p?=?0.003) and, accordingly, patients scanned at later time-points had a larger mean bias between the two tracers' liver uptake values (0.05 vs 1.46, p?=?0.001). Normal tissue biodistribution patterns of 68Ga-PSMA-11 and 18F-DCFPyL were similar, despite subtle differences in quantitative values. Liver uptake showed an acceptable intra-patient agreement and low inter-patient variability between the two tracers, allowing its use as a reference organ for thresholding scans in the qualitative comparison of PSMA expression using these different tracers.
机译:比较PSMA放射性配体的生物分布的详细数据仍然稀缺,提高了对不同化合物的可比性的担忧。我们调查了临床使用中两种最常见的PSMA示踪剂之间的正常器官生物分布和摄取变异性,68gA-PSMA-11和18F-DCFPYL之间的两个最常见的PSMA示踪剂。该回顾性分析包括34例肿瘤负担的患者,具有68ga-PSMA-11和随后的18°F-DCFPYL的PET / CT成像。用4个交叉校准PET / CT系统获得图像。将兴趣的体积置于主要的唾液和泪腺,肝脏,脾脏,十二指肠,肾脏,膀胱,血流池和肌肉上。然后将两种示踪剂的正常器官生物分布量定量为SUVPEAK,并使用配对测试,线性回归和Bland-Altman分析进行比较。还评估了患者之间的患者之间的变异性。研究了临床和协议变量以进行可能干扰。对于这两个示踪剂来说,肾脏和膀胱中发现的最高摄取量和低背景活动在所有扫描中都指出。在定量分析中,肾脏,脾脏和主要唾液腺中的68gA-PSMA-11产生了显着更高的摄取(P ?? 0.001),而肝脏表现出略高的18°F-DCPyl吸收(P?= 0.001,平均偏差0.79?±1.30)。在肝脏中发现最低的固体器官吸收可变性(COV 21.9%68gA-PSMA-11,21F-DCFPYL的22.5%)。 18F-DCFPYL吸收时间和肝脏SUVPEAK(R?= 0.488,P?= 0.003)之间存在较弱的相关性,因此,在稍后的时间点扫描的患者在两个示踪剂的肝脏吸收之间具有更大的平均偏差值(0.05 Vs 1.46,p?= 0.001)。尽管定量值细微差异,但是,常规组织生物分布模式为68gA-PSMA-11和18F-DCFPYL的模式。肝脏吸收显示了两个示踪剂之间的可接受的患者内部协议和低患者间可变性,允许其用作使用这些不同示踪剂的PSMA表达式的定性比较中的阈值扫描的参考器官。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号